Lurasidone Hydrochloride
Product Images NDC 82804-034

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lurasidone Hydrochloride (NDC 82804-034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lurasidone-fig1.jpg (Lurasidone Fig1)

A pharmacokinetic interaction chart showing the impact of various drugs on lurasidone. The x-axis represents fold change relative to lurasidone alone, with changes in Cmax and AUC indicated for each interacting drug, including ketoconazole, diltiazem, rifampin, and lithium. Confidence intervals are marked as horizontal lines centered on data points.*

FDA Label Image

Lurasidone-fig2.jpg (Lurasidone Fig2)

A dot plot chart depicting the fold change and 90% confidence intervals in pharmacokinetic measures (Cmax, AUC, or Ctrough) of various interacting drugs relative to the drug alone. Drugs include Digoxin 0.25 mg, Midazolam 5 mg, Ethinyl Estradiol, Norelgestromin, and Lithium 600 mg BID, grouped by P-gp substrates, CYP3A4 substrates, and oral contraceptives.*

FDA Label Image

Lurasidone-fig3.jpg (Lurasidone Fig3)

A pharmacokinetic chart illustrating fold changes and 90% confidence intervals in Cmax and AUC values relative to reference for lurasidone hydrochloride, comparing renal impairment (mild, moderate, severe), hepatic impairment (mild, moderate, severe), and population characteristics including gender (females) and race (Asian). The x-axis shows change relative to reference, with data points and error bars indicating variability.*

FDA Label Image

82804-034-30 (Lurasidone Fig4)

Label for lurasidone hydrochloride 20 mg tablets by Proficient Rx LP. The label indicates a quantity of 30 tablets with dosing information, a product ID XL003430, and manufacturer Piramal Pharma Limited, India. Includes storage instructions and safety warning to keep out of reach of children. Multiple small labels display batch and NDC 82804-034-30 details.*

FDA Label Image

Lurasidone-str.jpg (Lurasidone Str)

Chemical structure of lurasidone hydrochloride depicted as a molecular diagram, showing interconnected atoms and bonds characteristic of this active ingredient's chemical composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.